Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Brilacidin by Alfasigma for Proctitis: Likelihood of Approval
Brilacidin is under clinical development by Alfasigma and currently in Phase II for Proctitis. According to GlobalData, Phase II drugs...